» Articles » PMID: 19276390

Bicarbonate Increases Tumor PH and Inhibits Spontaneous Metastases

Overview
Journal Cancer Res
Specialty Oncology
Date 2009 Mar 12
PMID 19276390
Citations 313
Authors
Affiliations
Soon will be listed here.
Abstract

The external pH of solid tumors is acidic as a consequence of increased metabolism of glucose and poor perfusion. Acid pH has been shown to stimulate tumor cell invasion and metastasis in vitro and in cells before tail vein injection in vivo. The present study investigates whether inhibition of this tumor acidity will reduce the incidence of in vivo metastases. Here, we show that oral NaHCO(3) selectively increased the pH of tumors and reduced the formation of spontaneous metastases in mouse models of metastatic breast cancer. This treatment regimen was shown to significantly increase the extracellular pH, but not the intracellular pH, of tumors by (31)P magnetic resonance spectroscopy and the export of acid from growing tumors by fluorescence microscopy of tumors grown in window chambers. NaHCO(3) therapy also reduced the rate of lymph node involvement, yet did not affect the levels of circulating tumor cells, suggesting that reduced organ metastases were not due to increased intravasation. In contrast, NaHCO(3) therapy significantly reduced the formation of hepatic metastases following intrasplenic injection, suggesting that it did inhibit extravasation and colonization. In tail vein injections of alternative cancer models, bicarbonate had mixed results, inhibiting the formation of metastases from PC3M prostate cancer cells, but not those of B16 melanoma. Although the mechanism of this therapy is not known with certainty, low pH was shown to increase the release of active cathepsin B, an important matrix remodeling protease.

Citing Articles

Lactate and lactylation in cancer.

Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y Signal Transduct Target Ther. 2025; 10(1):38.

PMID: 39934144 PMC: 11814237. DOI: 10.1038/s41392-024-02082-x.


Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP.

Hiruma K, Bilim V, Kazama A, Shirono Y, Murata M, Tomita Y Curr Issues Mol Biol. 2025; 47(1.

PMID: 39852158 PMC: 11763506. DOI: 10.3390/cimb47010043.


Recent advances of anti-tumor nano-strategies via overturning pH gradient: alkalization and acidification.

Gong Q, Song X, Tong Y, Huo L, Zhao X, Han Y J Nanobiotechnology. 2025; 23(1):42.

PMID: 39849540 PMC: 11761731. DOI: 10.1186/s12951-025-03134-2.


Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity.

Zhao J, Hu S, Qi Z, Xu X, Long X, Huang A J Immunother Cancer. 2024; 12(12.

PMID: 39631851 PMC: 11624815. DOI: 10.1136/jitc-2024-009768.


Acid affairs in anti-tumour immunity.

Cappellesso F, Mazzone M, Virga F Cancer Cell Int. 2024; 24(1):354.

PMID: 39465367 PMC: 11514911. DOI: 10.1186/s12935-024-03520-0.


References
1.
Vaupel P, Kallinowski F, Okunieff P . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989; 49(23):6449-65. View

2.
Xu L, Fidler I . Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res. 2000; 60(16):4610-6. View

3.
Shi Q, Le X, Wang B, Abbruzzese J, Xiong Q, He Y . Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene. 2001; 20(28):3751-6. DOI: 10.1038/sj.onc.1204500. View

4.
Linebaugh B, Sameni M, Day N, Sloane B, Keppler D . Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem. 1999; 264(1):100-9. DOI: 10.1046/j.1432-1327.1999.00582.x. View

5.
Fidler I . Cancer metastasis. Br Med Bull. 1991; 47(1):157-77. DOI: 10.1093/oxfordjournals.bmb.a072453. View